home / stock / gwph / gwph news


GWPH News and Press, GW Pharmaceuticals Plc From 05/11/20

Stock Information

Company Name: GW Pharmaceuticals Plc
Stock Symbol: GWPH
Market: NASDAQ
Website: gwpharm.com

Menu

GWPH GWPH Quote GWPH Short GWPH News GWPH Articles GWPH Message Board
Get GWPH Alerts

News, Short Squeeze, Breakout and More Instantly...

GWPH - Marijuana Stock GW Pharmaceuticals Delivers Rapid Growth In Q1

GW Pharmaceuticals (NASDAQ: GWPH)  unveiled first-quarter financial results after the market closed on Monday, reporting revenue growth of 207% year over year to $120.6 million and a non- GAAP  loss of $0.02 per share, which beat analysts expectations by $0.05 per share. The biote...

GWPH - U.S. sales of GW Pharma's Epidiolex up 217% in Q1

GW Pharmaceuticals (NASDAQ: GWPH ) Q1 results : More news on: GW Pharmaceuticals plc, Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...

GWPH - GW Pharmaceuticals EPS beats by $0.05, beats on revenue

GW Pharmaceuticals (NASDAQ: GWPH ): Q1 GAAP EPS of -$0.02 beats by $0.05 . Revenue of $120.6M (+207.3% Y/Y) beats by $15.5M . Shares +1.9% . Press Release More news on: GW Pharmaceuticals plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news,

GWPH - GW Pharmaceuticals plc Reports First Quarter 2020 Financial Results and Operational Progress

- Total revenue of $120.6 million -  - Total Epidiolex® net product sales of $116.1 million -  - Conference call today at 4:30 p.m. EDT – LONDON and CARLSBAD, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), a world leader in the ...

GWPH - GW Pharmaceuticals Q1 2020 Earnings Preview

GW Pharmaceuticals (NASDAQ: GWPH ) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close. The consensus EPS Estimate is -$0.06 (+57.1% Y/Y) and the consensus Revenue Estimate is $105.1M (+167.8% Y/Y). Over the last 2 years, GWPH has beaten EPS estimates ...

GWPH - A $5 Billion Market Valuation for Psychedelics May be Too Low

Psychedelics have gone mainstream. All thanks to a wide range of research that points to success in treating a range of mental and other health related issues, including substance dependency, PTSD, anxiety, obsessive compulsive disorder, chronic pain, and even end-of-life anxiety. There&...

GWPH - Sun Kissed Industries, Inc.'s Numuni Subsidiary CEO, Robert Reynolds, To Discuss Power Of Digital Monetization Platform On Stock Market Podcast

Sun Kissed Industries, Inc.’s (OTC: SKDI) Numuni Inc. subsidiary CEO, Robert Reynolds, has received an invitation to discuss the power of its digital monetization platform at an upcoming Stock Market Podcast, the company announced today (May 7, 2020). Sun Kissed Industries, Inc. (...

GWPH - Sun Kissed Industries, Inc.'s Numuni Subsidiary Moves Into Revenue Generating Phase 2 Strategy, Sets Stock Market Podcast Interview

As Sun Kissed Industries, Inc.’s (OTC: SKDI) Numuni Inc.subsidiary moves into a revenue generating Phase 2, it is shifting away from being a R&D focused company into a firm which is integrating blockchain into a sales model in the digital marketing industry. It  markets and...

GWPH - Sun Kissed Industries, Inc.'s Hakuna CBD Product Subsidiary Introduces New Affiliate Marketing Program, Seeks Larger Client Base

Sun Kissed Industries, Inc.’s  (OTC: SKDI) Hakuna CBD products subsidiary today (May 6, 2020) announces it is launching a new Affiliate Marketing Program with the initial goal of 10-15 on-boarded marketers per month. The program rewards marketers for their efforts in increasing...

GWPH - Sun Kissed Industries, Inc.'s Hakuna Subsidiary Sees Sales Of Its CBD Biometric Sen-sor Storage Devices Causing Backlog Of Thousands Of Units

Sun Kissed Industries, Inc.’s  (OTC: SKDI) Hakuna subsidiary today (May 6, 2020) announces that its retail store clientele have placed increased orders for the company’s CBD Biometric Sensor Storage Devices that have resulted in a supply sellout and thousands of ordered ...

Previous 10 Next 10